Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

PHASE2TerminatedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

June 28, 2024

Study Completion Date

October 14, 2024

Conditions
Schizophrenia
Interventions
DRUG

Placebo

Oral tablets

DRUG

Luvadaxistat

Oral tablets

Trial Locations (49)

1000

Neurocrine Clinical Site, Sofia

1113

Neurocrine Clinical Site, Sofia

1408

Neurocrine Clinical Site, Sofia

1510

Neurocrine Clinical Site, Sofia

1680

Neurocrine Clinical Site, Sofia

4004

Neurocrine Clinical Site, Plovdiv

5800

Neurocrine Clinical Site, Pleven

10032

Neurocrine Clinical Site, New York

10035

Neurocrine Clinical Site, New York

11000

Neurocrine Clinical Site, Belgrade

11516

Neurocrine Clinical Site, Cedarhurst

18101

Neurocrine Clinical Site, Niš

18202

Neurocrine Clinical Site, Gornja Toponica

26220

Neurocrine Clinical Site, Kovin

28009

Neurocrine Clinical Site, Madrid

30338

Neurocrine Clinical Site, Atlanta

32502

Neurocrine Clinical Site, Pensacola

33016

Neurocrine Clinical Site, Miami

33133

Neurocrine Clinical Site, Miami

33144

Neurocrine Clinical Site, Miami

33176

Neurocrine Clinical Site, Miami

33180

Neurocrine Clinical Site, Aventura

33629

Neurocrine Clinical Site, Tampa

34000

Neurocrine Clinical Site, Kragujevac

34972

Neurocrine Clinical Site, Okeechobee

39232

Neurocrine Clinical Site, Flowood

48105

Neurocrine Clinical Site, Ann Arbor

60640

Neurocrine Clinical Site, Chicago

63128

Neurocrine Clinical Site, St Louis

63141

Neurocrine Clinical Site, St Louis

72022

Neurocrine Clinical Site, Bryant

72712

Neurocrine Clinical Site, Bentonville

75115

Neurocrine Clinical Site, DeSoto

77030

Neurocrine Clinical Site, Houston

85012

Neurocrine Clinical Site, Phoenix

90502

Neurocrine Clinical Site, Torrance

90660

Neurocrine Clinical Site, Pico Rivera

90706

Neurocrine Clinical Site, Bellflower

91206

Neurocrine Clinical Site, Glendale

92056

Neurocrine Clinical Site, Oceanside

92102

Neurocrine Clinical Site, San Diego

92103

Neurocrine Clinical Site, San Diego

92805

Neurocrine Clinical Site, Anaheim

92845

Neurocrine Clinical Site, Garden Grove

94305

Neurocrine Clinical Site, Stanford

94901

Neurocrine Clinical Site, San Rafael

301 00

Neurocrine Clinical Site, Pilsen

100 00

Neurocrine Clinical Site, Prague

160 00

Neurocrine Clinical Site, Prague

Sponsors
All Listed Sponsors
lead

Neurocrine Biosciences

INDUSTRY